Malaria parasites invade and replicate within red blood cells (RBCs), extensively 23 modifying their structure and gaining access to the extracellular environment by 24 placing the plasmodial surface anion channel (PSAC) into the RBC membrane. 25 Expression of members of the cytoadherence linked antigen gene 3 (clag3) family is 26 required for PSAC activity, a process that is regulated epigenetically. PSAC is a well-27 established route of uptake for large, hydrophilic antimalarial compounds and 28 parasites can acquire resistance by silencing clag3 gene expression, thereby 29 reducing drug uptake. We found that exposure to sub-IC50 concentrations of the 30 histone methyltransferase inhibitor chaetocin caused substantial changes in both 31 clag3 gene expression and RBC permeability, reversing acquired resistance to the 32 antimalarial compound blasticidin S that is transported through PSAC. Chaetocin 33 treatment also altered progression of parasites through their replicative cycle, 34 presumably by changing their ability to modify chromatin appropriately to enable 35 DNA replication. These results indicate that targeting histone modifiers could 36 represent a novel tool for reversing epigenetically acquired drug resistance in P. 37 falciparum. 38 39 Importance 40
Introduction
antimalarial compounds to the intracellular environment presents a potential new 106 mechanism for the development of drug resistance in the field, a troubling possibility 107 (22). However, with an understanding of the molecular basis of activation and 108 silencing of clag3.1/3.2, it might be possible to manipulate clag3.1/3.2 gene activity 109 and thereby reverse epigenetically acquired drug resistance and potentially increase 110 accessibility of parasites to antimalarial compounds. 111 Inhibitors of histone modifiers have been developed as potential therapeutic unknown, although the Plasmodium-specific kinase CRK4 was shown to play a key 121 role in this process (28). The heterochromatin mark H3K9me3 has been shown to 122 affect pre-initiation complex formation at origins (29) and rates of DNA replication 123 (30) in higher eukaryotic cells, thus inhibitors that affect H3K9me3 deposition would 124 be predicted to have interesting effects on schizogony, 125 In addition to their development as therapeutic compounds, inhibitors that 126 target various aspects of chromatin structure can also be used experimentally to 127 probe the function of specific histone modifications and decipher mechanisms that 128 regulate patterns of gene expression or cell replication. For example, we previously 129 utilized sub-IC50 concentrations of the histone methyltransferase inhibitor chaetocin 130 to investigate how changes in histone methylation efficiency affected patterns of var 131 gene expression switching (31). This inhibitor targets histone methyltransferases of 132 the SET3 family that deposit the histone mark H3K9me3 (32). In P. falciparum, this 133 mark is devoted almost exclusively to regulating transcription of clonally variant gene 134 families, which in addition to var genes also includes clag3. 1 The two alleles clag3 are located in close proximity to one another within a 154 ~20 kb segment of chromosome 3. The nucleosomes associated with the active or 155 silent allele have been shown to be marked by the histone post-translational 156 modifications H3K9ac or H3K9me3, respectively (13,17). When cultured parasites 157 were selected for resistance to antimalarial compounds that are taken up through 158 PSAC, both alleles were shown to acquire the H3K9me3 silencing mark, thus down-159 regulating total clag3 expression, reducing pore activity and enabling the parasites to 160 survive drug selection (13, 19, 20, 22) . Additional work showed that exposure to low 161 doses of blasticidin, a drug known to be taken up through PSAC, selects for 162 expression of clag 3.1, and silencing of both clag3.1 and clag3.2 when parasites are 163 exposed to high doses of blasticidin (13). These experiments demonstrated that the 164 two alleles differ somewhat in their ability to enable uptake of different compounds.
165
The small molecule chaetocin is an inhibitor of histone methyltransferases of 166 the SET3 variety that are responsible for deposition of H3K9me3, thus treatment of 167 cells with chaetocin can be used as a tool to investigate the role of this histone 168 modification in controlling gene expression. Previous work showed that treatment 169 with low levels of chaetocin induced significant changes in var gene expression (31), 170 presumably by reducing incorporation of H3K9me3 into the surrounding chromatin. 171 We were curious to see if treatment with chaetocin could similarly alter clag3.1/3.2 172 expression, and more specifically, to determine if treatment with this compound As expected, FCB wildtype parasites that had not been selected for 181 resistance to blasticidin displayed robust clag3 expression, with clag3.2 being the 182 dominantly expressed allele ( Figure 1 ). When these parasites were selected for 183 resistance to blasticidin, expression of clag3.2 was dramatically reduced, leading to 184 much lower overall clag3 expression levels, although a low level of clag3.1 185 expression remained largely unchanged. This is consistent with previous reports 186 showing that expression of clag3.2 is much more sensitive to blasticidin selection 187 due to more efficient uptake of the drug when this allele is expressed (13). Removal 188 of blasticidin pressure for 2 weeks led to a moderate increase in overall clag3 189 expression as the parasites began to revert to wildtype expression levels. The To obtain a more quantitative measurement of changes in sensitivity to 233 blasticidin, we performed drug sensitivity assays to identify changes in IC50 resulting 234 from chaetocin treatment. Blasticidin resistant FCB parasites were released from 235 blasticidin pressure and were grown in the presence or absence of three different 236 sub-IC50 concentrations of chaetocin (450, 600 and 750 nM) for thirteen days, then 237 drug sensitivity assays were performed using a standard sybr green growth assay 238 (34). As previously reported, this FCB line of parasites displayed a marked 239 resistance to blasticidin, however after exposure to all three concentrations of 240 chaetocin these parasites became much more sensitive to blasticidin and were 241 rapidly killed by concentrations known to kill most lines of P. falciparum (Figure 2B ).
242
The shift in sensitivity to blasticidin resulting from chaetocin exposure was not simply 243 the result of synergism between the two compounds since chaetocin treatment had 244 no effect on blasticidin sensitivity of wildtype parasites ( Figure 2C ). 
